|1.||Kusunoki, J: 3 articles (09/2001 - 04/2001)|
|2.||Aragane, K: 3 articles (09/2001 - 04/2001)|
|3.||Kojima, K: 3 articles (09/2001 - 04/2001)|
|4.||Fujinami, K: 3 articles (09/2001 - 04/2001)|
|5.||Kamei, J: 1 article (09/2001)|
|6.||Yamada, N: 1 article (08/2001)|
|7.||Chiwata, T: 1 article (08/2001)|
|8.||Ishibashi, S: 1 article (08/2001)|
09/01/2001 - "These results demonstrate that F-1394 both prevents the formation of atherosclerosis and accelerates its regression without affecting the serum TC level, indicating that F-1394 acts directly on the arterial wall."
09/01/2001 - "To clarify whether F-1394 accelerates the regression of preexisting atherosclerosis, rabbits were fed HCD for the first 6 weeks and then RC for the next 6 weeks. "
09/01/2001 - "To test its effect on the development of atherosclerosis, rabbits were fed a high-cholesterol diet (HCD) for 6 weeks, followed by regular chow (RC) for 12 weeks plus 0 or 100 mg/kg per day F-1394. "
08/01/2001 - "Here we have examined the effect of oral administration of an ACAT inhibitor, F-1394, on atherosclerosis in apoE/LDLr-DKO mice fed a regular chow diet. "
09/01/2001 - "Effect of F-1394, an acyl-CoA:cholesterol acyltransferase inhibitor, on atherosclerosis induced by high cholesterol diet in rabbits."
|2.||LDL Receptors (LDL Receptor)
|4.||Apolipoproteins E (ApoE)
|1.||Angioplasty (Angioplasty, Transluminal)